RU2001102046A - COMPOSITION CONTAINING, AT LEAST, ONE ACTING SUBSTANCE, INFLUENCING THE LEVEL OF LIPID CONTENT IN BLOOD - Google Patents
COMPOSITION CONTAINING, AT LEAST, ONE ACTING SUBSTANCE, INFLUENCING THE LEVEL OF LIPID CONTENT IN BLOODInfo
- Publication number
- RU2001102046A RU2001102046A RU2001102046/14A RU2001102046A RU2001102046A RU 2001102046 A RU2001102046 A RU 2001102046A RU 2001102046/14 A RU2001102046/14 A RU 2001102046/14A RU 2001102046 A RU2001102046 A RU 2001102046A RU 2001102046 A RU2001102046 A RU 2001102046A
- Authority
- RU
- Russia
- Prior art keywords
- paragraphs
- self
- drug
- active substance
- drug according
- Prior art date
Links
- 239000000126 substance Substances 0.000 title claims 14
- 150000002632 lipids Chemical class 0.000 title claims 3
- 210000004369 Blood Anatomy 0.000 title claims 2
- 239000008280 blood Substances 0.000 title claims 2
- 239000000203 mixture Substances 0.000 title 1
- 239000003814 drug Substances 0.000 claims 13
- 229940079593 drugs Drugs 0.000 claims 13
- 239000000853 adhesive Substances 0.000 claims 10
- 230000000694 effects Effects 0.000 claims 4
- 239000011159 matrix material Substances 0.000 claims 4
- 229960002965 Pravastatin Drugs 0.000 claims 2
- TUZYXOIXSAXUGO-PZAWKZKUSA-N Pravastatin Chemical compound C1=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(O)=O)[C@H]2[C@@H](OC(=O)[C@@H](C)CC)C[C@H](O)C=C21 TUZYXOIXSAXUGO-PZAWKZKUSA-N 0.000 claims 2
- 210000003491 Skin Anatomy 0.000 claims 2
- 229920000642 polymer Polymers 0.000 claims 2
- FJLGEFLZQAZZCD-JUFISIKESA-N (3S,5R)-fluvastatin Chemical compound C12=CC=CC=C2N(C(C)C)C(\C=C\[C@H](O)C[C@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 FJLGEFLZQAZZCD-JUFISIKESA-N 0.000 claims 1
- WMHRYMDGHQIARA-UHFFFAOYSA-N 4-hydroxyoxan-2-one Chemical class OC1CCOC(=O)C1 WMHRYMDGHQIARA-UHFFFAOYSA-N 0.000 claims 1
- SEERZIQQUAZTOL-ANMDKAQQSA-N Cerivastatin Chemical compound COCC1=C(C(C)C)N=C(C(C)C)C(\C=C\[C@@H](O)C[C@@H](O)CC(O)=O)=C1C1=CC=C(F)C=C1 SEERZIQQUAZTOL-ANMDKAQQSA-N 0.000 claims 1
- 206010062060 Hyperlipidaemia Diseases 0.000 claims 1
- 208000001252 Hyperlipoproteinemias Diseases 0.000 claims 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N Lovastatin Chemical group C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 claims 1
- AJLFOPYRIVGYMJ-INTXDZFKSA-N Mevastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 claims 1
- 229950009116 Mevastatin Drugs 0.000 claims 1
- 208000010125 Myocardial Infarction Diseases 0.000 claims 1
- 210000002381 Plasma Anatomy 0.000 claims 1
- 229920002367 Polyisobutene Polymers 0.000 claims 1
- 239000004793 Polystyrene Substances 0.000 claims 1
- RYMZZMVNJRMUDD-HGQWONQESA-N Simvastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)C(C)(C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 RYMZZMVNJRMUDD-HGQWONQESA-N 0.000 claims 1
- 206010040880 Skin irritation Diseases 0.000 claims 1
- 230000001070 adhesive Effects 0.000 claims 1
- 229960005370 atorvastatin Drugs 0.000 claims 1
- XUKUURHRXDUEBC-KAYWLYCHSA-N atorvastatin Chemical compound C=1C=CC=CC=1C1=C(C=2C=CC(F)=CC=2)N(CC[C@@H](O)C[C@@H](O)CC(O)=O)C(C(C)C)=C1C(=O)NC1=CC=CC=C1 XUKUURHRXDUEBC-KAYWLYCHSA-N 0.000 claims 1
- 229960005110 cerivastatin Drugs 0.000 claims 1
- VOLSCWDWGMWXGO-UHFFFAOYSA-N cyclobuten-1-yl acetate Chemical compound CC(=O)OC1=CCC1 VOLSCWDWGMWXGO-UHFFFAOYSA-N 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 229920001971 elastomer Polymers 0.000 claims 1
- 230000002708 enhancing Effects 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 239000005038 ethylene vinyl acetate Substances 0.000 claims 1
- 229960003765 fluvastatin Drugs 0.000 claims 1
- 230000037356 lipid metabolism Effects 0.000 claims 1
- 229960004844 lovastatin Drugs 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000155 melt Substances 0.000 claims 1
- 230000035515 penetration Effects 0.000 claims 1
- 239000004014 plasticizer Substances 0.000 claims 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 claims 1
- 229920000058 polyacrylate Polymers 0.000 claims 1
- 229920001195 polyisoprene Polymers 0.000 claims 1
- 229920001296 polysiloxane Polymers 0.000 claims 1
- 229920002223 polystyrene Polymers 0.000 claims 1
- 239000005060 rubber Substances 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 229960002855 simvastatin Drugs 0.000 claims 1
- 230000036556 skin irritation Effects 0.000 claims 1
- 231100000475 skin irritation Toxicity 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 230000001225 therapeutic Effects 0.000 claims 1
- 201000011528 vascular disease Diseases 0.000 claims 1
Claims (14)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19830732.2 | 1998-07-09 | ||
DE19830732A DE19830732B4 (en) | 1998-07-09 | 1998-07-09 | Composition containing at least one substance influencing blood lipid levels and its use |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2001102046A true RU2001102046A (en) | 2003-01-20 |
RU2227023C2 RU2227023C2 (en) | 2004-04-20 |
Family
ID=7873488
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2001102046/15A RU2227023C2 (en) | 1998-07-09 | 1999-07-07 | Composition containing at least one active substance influencing on blood lipid level |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1094797B1 (en) |
JP (1) | JP2002520272A (en) |
KR (1) | KR100549848B1 (en) |
CN (1) | CN1309377C (en) |
AR (1) | AR019902A1 (en) |
AT (1) | ATE278395T1 (en) |
AU (1) | AU770573B2 (en) |
BR (1) | BR9911941A (en) |
CA (1) | CA2336712C (en) |
CZ (1) | CZ300976B6 (en) |
DE (2) | DE19830732B4 (en) |
ES (1) | ES2230872T3 (en) |
HU (1) | HU226614B1 (en) |
IL (2) | IL140667A0 (en) |
MX (1) | MXPA01000126A (en) |
NZ (1) | NZ509215A (en) |
PL (1) | PL194983B1 (en) |
RU (1) | RU2227023C2 (en) |
TR (1) | TR200100021T2 (en) |
TW (1) | TWI237572B (en) |
WO (1) | WO2000002541A1 (en) |
ZA (1) | ZA200100171B (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL189890B1 (en) * | 1999-09-14 | 2005-10-31 | Kazmierski Jan Zaklad Prod Usl | Preparation for protecting plants against diseases |
AU2003264443A1 (en) * | 2002-09-20 | 2004-04-08 | Kowa Co., Ltd. | Preparation for external use |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
AU2004203700B2 (en) * | 2003-01-02 | 2007-06-21 | Femmepharma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
WO2005094814A1 (en) * | 2004-03-31 | 2005-10-13 | Kowa Co., Ltd. | External preparation |
EP1611882B1 (en) | 2004-06-01 | 2010-04-07 | Hisamitsu Pharmaceutical Co., Inc. | Adhesive patch |
JP4986411B2 (en) * | 2004-06-01 | 2012-07-25 | 久光製薬株式会社 | Patch |
US20050281868A1 (en) * | 2004-06-21 | 2005-12-22 | Fairfield Clinical Trials, Llc | Transdermal delivery system for statin combination therapy |
DE102004062182B4 (en) * | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient |
EP1996118A4 (en) * | 2006-03-07 | 2013-03-06 | Osteoscreen Ip Llc | Hmg co-a reductase inhibitor enhancement of bone and cartilage |
KR100817274B1 (en) * | 2006-08-21 | 2008-03-27 | 삼성전기주식회사 | Light emitting diode package and method of manufacturing the same |
EP3556359A4 (en) | 2016-12-19 | 2020-08-05 | Nutritape, S.L. | Energising patch for sportspeople |
EP3938076A1 (en) | 2019-03-12 | 2022-01-19 | Corning Incorporated | Ceramic honeycomb body with skin |
TWI803052B (en) * | 2021-11-12 | 2023-05-21 | 佛教慈濟醫療財團法人 | Transdermal delivery device, methods of using and making the same |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3634016A1 (en) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE |
US5503844A (en) * | 1993-05-18 | 1996-04-02 | Mli Acquisition Corp. Ii | Foam laminate transdermal patch |
FR2719220A1 (en) * | 1994-04-29 | 1995-11-03 | Lafon Labor | New galenic form for transdermal administration. |
DE69524614T2 (en) * | 1994-10-05 | 2002-09-12 | Hisamitsu Pharmaceutical Co | MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION |
DE19541260A1 (en) * | 1995-11-06 | 1997-05-07 | Lohmann Therapie Syst Lts | Therapeutic preparation for transdermal application of active ingredients through the skin |
WO1999024032A1 (en) * | 1997-11-10 | 1999-05-20 | Novo Nordisk A/S | Transdermal delivery of 3,4-diarylchromans |
-
1998
- 1998-07-09 DE DE19830732A patent/DE19830732B4/en not_active Expired - Lifetime
-
1999
- 1999-07-06 TW TW088111470A patent/TWI237572B/en not_active IP Right Cessation
- 1999-07-07 PL PL345510A patent/PL194983B1/en unknown
- 1999-07-07 RU RU2001102046/15A patent/RU2227023C2/en active
- 1999-07-07 WO PCT/EP1999/004757 patent/WO2000002541A1/en active IP Right Grant
- 1999-07-07 AR ARP990103304A patent/AR019902A1/en active IP Right Grant
- 1999-07-07 CN CNB998084255A patent/CN1309377C/en not_active Expired - Lifetime
- 1999-07-07 DE DE59910758T patent/DE59910758D1/en not_active Expired - Lifetime
- 1999-07-07 JP JP2000558801A patent/JP2002520272A/en active Pending
- 1999-07-07 IL IL14066799A patent/IL140667A0/en active IP Right Grant
- 1999-07-07 MX MXPA01000126A patent/MXPA01000126A/en active IP Right Grant
- 1999-07-07 AT AT99936490T patent/ATE278395T1/en not_active IP Right Cessation
- 1999-07-07 CA CA002336712A patent/CA2336712C/en not_active Expired - Lifetime
- 1999-07-07 BR BR9911941-2A patent/BR9911941A/en not_active Application Discontinuation
- 1999-07-07 KR KR1020017000286A patent/KR100549848B1/en not_active IP Right Cessation
- 1999-07-07 TR TR2001/00021T patent/TR200100021T2/en unknown
- 1999-07-07 EP EP99936490A patent/EP1094797B1/en not_active Expired - Lifetime
- 1999-07-07 CZ CZ20010093A patent/CZ300976B6/en unknown
- 1999-07-07 HU HU0102718A patent/HU226614B1/en unknown
- 1999-07-07 NZ NZ509215A patent/NZ509215A/en not_active IP Right Cessation
- 1999-07-07 ES ES99936490T patent/ES2230872T3/en not_active Expired - Lifetime
- 1999-07-07 AU AU51574/99A patent/AU770573B2/en not_active Expired
-
2001
- 2001-01-01 IL IL140667A patent/IL140667A/en not_active IP Right Cessation
- 2001-01-08 ZA ZA200100171A patent/ZA200100171B/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2001102046A (en) | COMPOSITION CONTAINING, AT LEAST, ONE ACTING SUBSTANCE, INFLUENCING THE LEVEL OF LIPID CONTENT IN BLOOD | |
FI95775B (en) | A method of making a transdermal therapeutic system for administering physostigmine to the skin | |
AU2007325918B2 (en) | Transdermal delivery systems comprising bupivacaine | |
CA2125662C (en) | Transdermally administered system containing acetylsalicylic acid for thrombosis therapy and cancer prophylaxis | |
RU2227023C2 (en) | Composition containing at least one active substance influencing on blood lipid level | |
KR101054317B1 (en) | Transepidermal drug delivery system containing rivastigmine | |
EP2223686B1 (en) | Patch and patch preparation | |
IE66737B1 (en) | Superficial therapeutic system comprising an antineoplastic active substance particularly 5-fluorouracil | |
CA2006425C (en) | Transdermal therapeutical system comprising norpseudoephedrine as active component | |
KR100746809B1 (en) | Plaster for the treatment of dysfunctions and disorders of nails | |
US5705186A (en) | Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide | |
KR950013448B1 (en) | Patch type pneparation | |
JP3064402B2 (en) | Patch containing isosorbide dinitrate | |
KR100254573B1 (en) | Transdermal therapeutic system for administering physostigmin through the skin, and a method of producing the system | |
KR20060052931A (en) | Transdermal warfarin-containing delivery system | |
CA2336704A1 (en) | Composition containing glycerol trinitrate, method for producing said composition and use of the same | |
AU2013202352B2 (en) | Transdermal delivery systems comprising bupivacaine |